LDOC1 Antikörper (N-Term)

Produktnummer ABIN927753

Produktdetails anti-LDOC1 Antikörper

Target: LDOC1 (Leucine Zipper, Down-Regulated in Cancer 1 (LDOC1))

Bindungsspezifität: N-Term

Reaktivität: Human, Rind (Kuh)

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser LDOC1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Kreuzreaktivität: Rind (Kuh)

Aufreinigung: Purified

Immunogen: LDOC1 antibody was raised in rabbit using the N terminal of LDOC1 as the immunogen

Anwendungsinformationen

Applikationshinweise: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

LDOC1 Blocking Peptide, catalog no. 33R-6579, is also available for use as a blocking control in assays to test for specificity of this LDOC1 antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Details zu LDOC1

Target: LDOC1 (Leucine Zipper, Down-Regulated in Cancer 1 (LDOC1))

Andere Bezeichnung: LDOC1 (LDOC1 Produkte)

Hintergrund: LDOC1 contains a leucine zipper-like motif and a proline-rich region that shares marked similarity with an SH3-binding domain. The protein localizes to the nucleus and is down-regulated in some cancer cell lines. It is thought to regulate the transcriptional response mediated by the nuclear factor kappa B (NF-kappaB). The gene has been proposed as a tumor suppressor gene whose protein product may have an important role in the development and/or progression of some cancers. Synonyms: Polyclonal LDOC1 antibody, Anti-LDOC1 antibody, leucine zipper, down-regulated in cancer 1 antibody, BCUR1 antibody, Mar7 antibody, Mart7 antibody.